Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

NCT02929251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Biotherapy

Interventions

DRUG: Anakinra
DRUG: Tocilizumab
DRUG: Adalimumab

Sponsor

Assistance Publique - Hôpitaux de Paris